Biosafe Pharmaceuticals Private Limited, a active private limited company, was established on 17 April 2010 in Ambarnath, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U52311MH2010PTC202132. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Santosh Kumar Singh (Director), Vivek Kumar Surendra Sharma (Director), Sunil Kumar Harishankar Mishra (Director). Past directors included Rajesh Girijashankar Tiwari. It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No.240,2Nd Floor,, Globe Business Park,Kalyan-Badlapur Road,Ambarnath, Thane, Ambarnath, Maharashtra, 421505.
U52311MH2010PTC202132
202132
17 April 2010
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Biosafe Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Kumar Singh | Director | 03 Jan 2014 | Current |
| Vivek Kumar Surendra Sharma | Director | 17 Apr 2010 | Current |
| Sunil Kumar Harishankar Mishra | Director | 17 Apr 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Aug 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biosafe Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 39.86% increase. The company also saw a substantial improvement in profitability, with a 64.97% increase in profit. The company's net worth Soared by an impressive increase of 100.33%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Biosafe Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Sep 2023 | Others | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Biosafe Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biosafe Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biosafe Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Biosafe Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Biosafe Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 2.50 M with Charge ID 100790584 was registered on 30 Sep 2023. was documented.
Progress on Santosh Kumar Singh was appointed as a Director was appointed as a Director on 03 Jan 2014 & has been associated with this company since 11 years 11 months . was documented.
Progress on Vivek Kumar Surendra Sharma was appointed as a Director was appointed as a Director on 17 Apr 2010 & has been associated with this company since 15 years 7 months . was documented.
The activity Sunil Kumar Harishankar Mishra was appointed as a Director was appointed as a Director on 17 Apr 2010 & has been associated with this company since 15 years 7 months . was completed.
The CIN of Biosafe Pharmaceuticals Private Limited is U52311MH2010PTC202132.
Biosafe Pharmaceuticals Private Limited is headquartered at Unit No.240,2Nd Floor,, Globe Business Park,Kalyan-Badlapur Road,Ambarnath, Thane, Ambarnath, Maharashtra, 421505.
Biosafe Pharmaceuticals Private Limited was incorporated on 17 April 2010.
The current directors of Biosafe Pharmaceuticals Private Limited are
The primary industry of Biosafe Pharmaceuticals Private Limited is Manufacturing.
Biosafe Pharmaceuticals Private Limited is unlisted.
The authorized capital of Biosafe Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Biosafe Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX